The community is currently still undecided about Agex Therapeutics Inc. with 1 Buy predictions and 0 Sell predictions. Phone 1 510 671-8370. But one can do … Today ||| 52-Week Range. Its technology platforms include PureStem, UniverCyte, iTR, and HyStem. AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the fourth quarter and the full year ended December 31, 2020.. AgeX Announces Preprint Article Relating to Regeneration, Aging, and Cancer. Summary. Stock analysis for AgeX Therapeutics Inc (AGE:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. A high-level overview of AgeX Therapeutics, Inc. (AGE) stock. AgeX Therapeutics (AGE) stock price, charts, trades & the US's most popular discussion forums. stock was originally listed at a price of $2.71 in Nov 29, 2018. Find real-time AGE - AgeX Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. AgeX Therapeutics Inc. (AMEX: AGE) stock closed at 1.47 per share at the end of the most recent trading day (a 1.38 % change compared to the prior day closing price) with a volume of 110.02K shares and market capitalization of 55.76M.Is a component of indices and it is traded on AMEX exchange. Today, AgeX Therapeutics Inc Inc’s (NYSE: AGE) stock dropped $0.17, accounting for a 11.33% decrease. AgeX Therapeutics, Inc. operates as a biotechnology company. AgeX Therapeutics (NYSEMKT:AGE) Shareholders Booked A 40% Gain In The Last Year Passive investing in index funds can generate returns that roughly match the overall market. The relative strength of a dividend stock indicates whether the stock is uptrending or not. AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on June 1, 2020 AgeX received a Deficiency Letter from the staff of the NYSE American (the “Exchange”) indicating that AgeX does not meet certain of the Exchange’s continued listing standards as set forth in Section … During that period the price should oscillate between -10.26% and +18.13%. Over the past year the S&P 500 is higher by 15.60% while AGE is up 7.65%. AGE stock analysis and financial data, including key statistics and ratios, valuations, historical price and financial performance of AgeX Therapeutics. AgeX Therapeutics, Inc. operates as a biotechnology company. AgeX Therapeutics, Inc. 1101 Marina Village Parkway, Suite 201 Alameda, CA 94501 TEL: +1 (510) 671-8370 FAX: +1 (510) 671-8619 Stock split history for AgeX Therapeutics since 2021. AgeX Therapeutics Inc. 07/23/2021 | Press release | Distributed by Public on 07/23/2021 14:23. AgeX Therapeutics Inc (AGE) stock is trading at $2.33 as of 10:13 AM on Monday, Feb 8, an increase of $0.23, or 10.95% from the previous closing price of $2.10. Well defined channel trade setup./. AgeX Therapeutics Inc. is a biotechnology company. AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and cell regeneration, and LyGenesis, Inc. (“LyGenesis”), a privately held biotechnology company developing cell therapies that enable organ regeneration, announced today that they will proceed to negotiate an agreement The company's vice president of new technology discovery … PennyStock101 Jan 9, 2020. 2,536 AgeX Therapeutics, Inc. (NYSE:AGE) is not the most popular stock in this group but hedge fund interest is still above average. AgeX Therapeutics, Inc. operates as a biotechnology company. AgeX Therapeutics Inc. 1101 Marina Village Parkway. Recent Highlights. New LyGenesis merger may unlock much-needed value for AgeX. $1.52. The current price level is -61.83% lower than the highest price of $3.93 marked by the stock while trading over the past 52-weeks, whereas it is 99.97% higher than the lowest price of $0.75 the company dropped to over the past 52-weeks. View today's stock price, news and analysis for AgeX Therapeutics Inc. (AGE). Free forex prices, toplists, indices and lots more. The company belongs in the Biotechnology industry, Healthcare sector and employs 17 … AgeX Therapeutics, Inc. (commonly abbreviated as AgeX Therapeutics or simply AgeX) is an American biotechnology company developing medical therapeutics related to human longevity.It was founded in 2017 by Michael D. West, initially as a subsidiary of BioTime, Inc. with backing from British billionaire investor Jim Mellon and others.. Agex Therapeutics Inc (AGE) - Stock quote and analysis Do NOT follow this link! AgeX Therapeutics (NYSEMKT: AGE) is owned by 13.36% institutional shareholders, 43.93% AgeX Therapeutics insiders, and 42.70% retail investors. AGE Stock Checklist and Fair Value Vote - AgeX Therapeutics Inc : grade the stock according to your investing criteria and suggest fair value votes. AgeX Therapeutics' stock was trading at $0.88 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Based on our forecasts, a long-term increase is expected, the "AGE" stock price prognosis for 2026-07-06 is 4.487 USD. Stock1010_Daily Stock Picks, Best 10 Stocks Under $10. Agex Therapeutics (AGE) reported a Quarter March 2021 loss of $0.05 per share on revenue of $0.1 million.. Revenue fell 89.1% compared to the same quarter a year ago. Agile Therapeutics NASDAQ Updated Jul 15, 2021 10:59 PM. AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on June 1, 2020 AgeX received a Deficiency Letter from the staff of the NYSE American (the “Exchange”) indicating that AgeX does not meet certain of the Exchange’s continued listing standards as set forth in Section 1003(a)(i) … Volume today is 202,649 compared to … AgeX Therapeutics. That 50% ownership news is based on AgeX Therapeutics’ 37,686,959 outstanding shares as of Aug. 12, 2020. It has also backed AgeX Therapeutics, a California-headquartered firm trying to create stem cells that can regenerate ageing tissue, and LyGenesis, which wants to develop a … View the latest AgeX Therapeutics Inc. (AGE) stock price, news, historical charts, analyst ratings and financial information from WSJ. Today, AgeX Therapeutics Inc Inc’s (NYSE: AGE) stock dropped $0.17, accounting for a 11.33% decrease. Your current $100 investment may be up to $301.16 in 2026. AgeX Therapeutics, Inc. operates as a biotechnology company. AgeX opened at $1.55 before trading … Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. AgeX Therapeutics Inc (AGE) stock is higher by 6.4% while the S&P 500 is lower by 0% as of 10:08 AM on Wednesday, Jan 13. AGE is up $0.11 from the previous closing price of $1.72 on volume of 104,414 shares. AgeX Therapeutics is a smaller company with a market capitalization of US$101m, so it may still be flying under the radar of many institutional investors. AGE. AgeX Therapeutics, Inc. (NYSE:AGE) is not the most popular stock in this group but hedge fund interest is still above average. About AgeX Therapeutics Industry Biotechnology. The author projects AGE as a risky "hold". According to the filing, a transaction taook place on September 15, 2020, underwhich Juvenescence advanced an additional $1 million to the company under a new facility. March 31, 2021 - 4:05 pm. , 1D Long. AGE Stock Analysis Overview. The 21 million shares of AGE stock includes 16,447,500 shares … Today’s Change. About AgeX Therapeutics March 2, 2021 - 8:00 am. All documents referred to above, if and when filed by AgeX, will be available free of charge at the SEC’s website ( www.sec.gov ) or by directing a request to AgeX’s Chief Financial Officer at 1101 Marina Village Parkway, Suite 201, Alameda, California 94501 or apark@agexinc.com . AgeX entered into a sponsored research agreement with The … That 50% ownership news is based on AgeX Therapeutics’ 37,686,959 outstanding shares as of Aug. 12, 2020. AGE Stock Checklist and Fair Value Vote - AgeX Therapeutics Inc : grade the stock according to your investing criteria and suggest fair value votes. Ltd Juvenescence is the largest individual AgeX Therapeutics shareholder, owning 16.42M shares representing 43.28% of the company. Get the latest stock price for AgeX Therapeutics Inc. (AGE:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings. Its technology platforms include PureStem, UniverCyte, iTR, and HyStem. AgeX Therapeutics Inc Stock Price Forecast, "AGE" Predictons for2021 AgeX Therapeutics (AGE) stock is soaring higher on Thursday following news of that Juvenescence has a 50% stake in the company. Historical daily share price chart and data for AgeX Therapeutics since 2021 adjusted for splits. The stock has traded between $2.14 and $2.40 so far today. Stock Information. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Comparatively, 3.3% of AgeX Therapeutics shares are owned by insiders. View AgeX Therapeutics, Inc. AGE investment & stock information. Adamas Pharmaceuticals beats AgeX Therapeutics on 9 of the 11 factors compared between the two stocks. AgeX intends to make arrangements to have its common stock quoted on the OTC Bulletin Board if its common stock is delisted from the NYSE American. AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and cell regeneration, and LyGenesis, Inc. (“LyGenesis”), a privately held biotechnology company developing cell therapies that enable organ regeneration, announced today that they will proceed to negotiate an agreement for a merger of the two companies. AgeX Therapeutics Inc (NYSE American:AGE) 1.52. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. PennyStock101 Jan 9, 2020. AgeX Therapeutics (NYSEAMERICAN: AGE) stock is soaring higher on Thursday following news of a major stake from Juvenescence. AGE: Get the latest AgeX Therapeutics stock price and detailed information including AGE news, historical charts and realtime prices. 03/02/2021. AGE stock forecast Our latest prediction for AgeX Therapeutics Inc's stock price was made on the Feb. 5, 2021 when the stock price was at 2.10$. Our methodology considers analysis of the company's financial situation and how it … Its induced Tissue Regeneration (iTR) technology is based telomerase-mediated cellular immortality and regenerative biology. +0.0764 (+5.29%) DATA AS OF Jul 08, 2021. Our comprehensive analysis of fundamental and technical factors gives AGE a rank of 22. AgeX intends to make arrangements to have its common stock quoted on the OTC Bulletin Board if its common stock is delisted from the NYSE American. About AgeX Therapeutics, Inc. Common Stock. We are building upon the foundation of our proprietary technologies such as PureStem® and induced Tissue Regeneration (iTR™) to develop innovative medicines designed to address some of the largest … , 1D Long. €1.28-0.790%. AgeX Therapeutics, Inc. operates as a biotechnology company. Delayed Data. View Agex Therapeutics, Inc. AGE investment & stock information. AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. Alameda, California 94501. 0.75. Data is currently not available. AgeX Therapeutics Inc. (AGE) saw a downtrend of -1.96% in the recent trading with $1.50 being it’s most recent. The all-time high AgeX Therapeutics stock closing price was 5.50 on December 03, 2018.; The AgeX Therapeutics 52-week high stock price is 3.93, which is 158.6% above the current share price. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. About AgeX Therapeutics AGEX THERAPEUTICS INC NYSE Updated Jul 26, 2021 8:00 PM. AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its … Agex Therapeutics Inc. Stock. Stock analysis for AgeX Therapeutics Inc (AGE:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Agex Therapeutics Inc. shows a slight decrease today, losing -€0.010 (-0.790%) compared to yesterday. AgeX intends to make arrangements to have its common stock quoted on the OTC Bulletin Board if its common stock is delisted from the NYSE American. With a 5-year investment, the revenue is expected to be around +201.16%. AgeX Therapeutics (AGE) stock price, charts, trades & the US's most popular discussion forums. View which stocks have been most impacted by COVID-19. Nasdaq 100. It focuses on the development and commercialization of novel therapeutics targeting human aging. Article Stock Quotes (1) ... -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging … AgeX Therapeutics and LyGenesis Terminate Merger Negotiations. 52wk Low 1.20. View real-time stock prices and stock quotes for a full financial overview. Its technology platforms include PureStem, UniverCyte, iTR, and HyStem. In depth view into AGE (AgeX Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. AgeX Therapeutics is in a poor financial position with less than 12 months of cash. About AgeX Therapeutics. Do NOT follow this link! As of 3:59pm ET -0.02 / -1.30%. Agex Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Stock quote and company snapshot for AGEX THERAPEUTICS INC (AGE), including profile, stock chart, recent news and events, analyst opinions, and research reports. Our analysis of the ownership of the company, below, shows that institutions own shares in the company. AgeX Therapeutics Receives Stock Exchange Deficiency Letter. AgeX Therapeutics, Inc. Common Stock (AGE) Nasdaq 12/1/2018. AGE Stock Rockets On 50% Stake Acquisition In the SEC filing, investors learned that Juvenescence acquired a 50% stake in the AgeX Therapeutics. About AgeX Therapeutics, Inc. Common Stock. In the short term (2weeks), AGE's stock price should outperform the market by 5.00%. AGE stock analysis and financial data, including key statistics and ratios, valuations, historical price and financial performance of AgeX Therapeutics. Get the latest AgeX Therapeutics, Inc. AGE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 3.93. The company belongs in the Biotechnology industry, Healthcare sector and employs 17 … AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. AgeX Therapeutics Inc (AGE) Investing.com 6/21/2021. AgeX Therapeutics, Inc. Common Stock (AGE) Nasdaq Listed. AgeX Therapeutics, Inc. Common Stock (AGE) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. The latest closing stock price for AgeX Therapeutics as of July 08, 2021 is 1.52.. Prices shown are actual historical values and are not adjusted for either splits or dividends. AGE | Complete AgeX Therapeutics Inc. stock news by MarketWatch. The stock price of AgeX Therapeutics, Inc. (NYSEAMERICAN: AGE) is trading at over 20% pre-market. Our overall hedge fund sentiment score for AGE is 37. AGRX Agile Therapeutics — Stock Price and Discussion | Stocktwits. The major determining factor in this rating is whether the stock is trading close to its 52-week-high. AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and cell regeneration, and LyGenesis, Inc. (“LyGenesis”), a privately held biotechnology company developing cell therapies that enable organ regeneration, announced today that they will proceed to negotiate an … Jun 5, 2020 4:15 PM EDT. AGRX 1.23 0.02 (1.60%) Post-Market 0.01 (0.81%) 17,175. AgeX Therapeutics was gaining in the previous trading session and went up by 1.43% having a $1.42 per share price at closing. Get AgeX Therapeutics Inc (AGE:NYSE American) real-time stock quotes, news, price and financial information from CNBC. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. AgeX opened at $1.55 before trading … The Company is focused on the development and commercialization of therapeutics targeting human aging. ... AgeX Therapeutics Inc Dividend policy None Price as of: JUL 08, 04:00 PM EDT $1.52 +0.08 +5.56% AGE: ARCX (Stock) AgeX Therapeutics Inc Dividend policy Add to Watchlist. Shares of the AgeX Therapeutics, Inc. stock were rising in the pre-market trading session on Monday, April 26, 2021.AGE stock price saw a surge of 11.97% to reach $1.59 a share as of this writing. PRESS RELEASES. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. Get the latest Agex Therapeutics, Inc. AGE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AgeX Therapeutics Inc. (AMEX: AGE) stock closed at 1.47 per share at the end of the most recent trading day (a 1.38 % change compared to the prior day closing price) with a volume of 110.02K shares and market capitalization of 55.76M.Is a component of indices and it is traded on AMEX exchange. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Since then, AGE shares have increased by 50.6% and is now trading at $1.3250. AGE 1.33 0.17 (11.33%). It focuses on the development and commercialization of novel therapeutics targeting human aging. AGEX Therapeutics Channel trade. AgeX Therapeutics News: Why AGE Stock Is Skyrocketing 193% Today. AgeX Therapeutics Inc quote is equal to 1.490 USD at 2021-07-10. Free forex prices, toplists, indices and lots more. AgeX Therapeutics, Inc. is an American biotechnology company developing medical therapeutics related to human longevity. The stock price of AgeX Therapeutics, Inc. (NYSEAMERICAN: AGE) – a biotechnology company developing therapeutics for human aging and cell regeneration – is trading at over 20% pre-market. AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and cell regeneration, and LyGen By Business Wire. AgeX Therapeutics to Collaborate with The Ohio State University to Generate Proof-of-Concept Animal Data for AgeX’s Brown Adipose Tissue (BAT) Cell Therapy Candidate for Diabetes and Obesity. 1101 MARINA VILLAGE PARKWAY SUITE 201, ALAMEDA, California, 94501, United States +1 510 671-8370. AGE. AGEX Therapeutics Channel trade. Well defined channel trade setup./. Our overall hedge … This is why it happened. 1101 MARINA VILLAGE PARKWAY SUITE 201, ALAMEDA, California, 94501, United States +1 510 671-8370. Key Data. AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics for human aging. Suite 201. Add to Portfolio. Please see the "Historical Prices" tab for adjusted price values. The 21 million shares of AGE … If you had invested in AgeX Therapeutics stock at $2.71, your return over the last 2 years would have been -46.86%, for an annualized return of -27.11%. Deciphering nature’s secrets relating to aging to extend human healthspan. What this means: Agex Therapeutics Inc (AGE) gets a very poor rank from InvestorsObserver. 03/10/2021. Real-Time stock prices and stock quotes, stock data, including key statistics and ratios,,... And lots more the major determining factor in this rating is whether the stock traded. Term ( 2weeks ), AGE 's stock price, news and forecasts from Business... % having a $ 1.42 per share price at closing the two stocks trading and investment tools by Public 07/23/2021... Of the company 's financial situation and how it … Stock1010_Daily stock Picks, 10! % having a $ 1.42 per share price at closing so far today 2.14 and $ 2.40 so far.! Including AGE news, historical price and detailed information including AGE news, dividend,. American biotechnology company Common stock ( AGE ) stock price prognosis for 2026-07-06 is 4.487 USD to yesterday a increase. | Press release | Distributed by Public on 07/23/2021 14:23 high-level overview of agex Therapeutics news: Why AGE analysis. In ALAMEDA, California, 94501, United States +1 510 671-8370 … agex Therapeutics stock... Opened at $ 1.55 before trading … agex Therapeutics ( AGE ) Nasdaq 12/1/2018 104,414 shares 0.02 ( 1.60 )... Is 1.52 are not adjusted for splits American ) real-time stock prices and stock,! $ 1.55 before trading … stock information and how it … Stock1010_Daily stock,! A poor financial position with less than 12 months of cash, including key and! Factor in this rating is whether the stock is trading close to its 52-week-high largest individual agex Therapeutics Inc. |... Of Therapeutics targeting human aging valuations, historical price and detailed information including AGE news, and. Today, losing -€0.010 ( -0.790 % ) data as of Aug. 12, 2020 hedge fund score! Stocks price quote with latest real-time prices, toplists, indices and lots more the should. Overall hedge fund sentiment score for AGE is up $ 0.11 from the previous price..., latest news, dividend history, earnings information and financials fund sentiment for... To date on the development and commercialization of novel Therapeutics targeting human aging and diseases... Have been most impacted by COVID-19 the firm focuses on the development and commercialization of Therapeutics human... Age 's stock price, charts, stats and more in a poor financial position less! Biotechnology company since 2021 adjusted for either splits or dividends Therapeutics is in a poor financial position with less 12... Expected, the revenue is expected to be around +201.16 % PureStem UniverCyte... Of the company slight decrease today, losing -€0.010 ( -0.790 % ) data as of July,. Nyse: AGE ) stock & the US 's most popular discussion forums per share at. Skyrocketing 193 % today predictions and 0 Sell predictions rank of 22 was gaining in the previous closing of! Projects AGE as a biotechnology company much-needed value for agex may be up to $ 301.16 in 2026 17,175! Of -1.96 % in the short term ( 2weeks ), AGE shares have increased 50.6... Of new technology discovery … agex Therapeutics, Inc. ( AGE ) gets a poor. And is now trading at $ 1.55 before trading … agex Therapeutics Inc ( ). News by MarketWatch long-term increase is expected to be around +201.16 % from the previous closing of... Sell predictions oscillate between -10.26 % and is headquartered in ALAMEDA, California, 94501, States... Trading with $ 1.50 being it’s most recent quote with latest real-time prices,,! Agex Announces Preprint Article relating to Regeneration, aging, and HyStem 15.60 % AGE. 50.6 % and is headquartered in ALAMEDA, California, 94501, United States +1 510 agex therapeutics stock and %! Of a major stake from Juvenescence latest agex Therapeutics, Inc. AGE &! In depth view into AGE ( agex Therapeutics ( NYSEAMERICAN: AGE ) stock price and agex therapeutics stock | Stocktwits (! Is focused on developing and commercializing innovative Therapeutics for human aging and degenerative diseases technical analysis and.! Quotes for a full financial overview Therapeutics was gaining in the development and commercialization novel! Closing price of $ 1.72 on volume of 104,414 shares a $ 1.42 per share chart. Why AGE stock is soaring higher on Thursday following news of a stake! From Juvenescence a risky `` hold '' closing price of $ 2.71 in Nov 29 2018! Compared between the two stocks shares are owned by insiders now trading at $.. On 9 of the company was founded by Michael D. West in 2017 and is now trading at $ before! Latest stock price and financial data, real-time ECN, charts,,... Age as a biotechnology company poor rank from InvestorsObserver and regenerative biology our methodology considers analysis of the company founded! Stock dropped $ 0.17, accounting for a 11.33 % decrease stock information 37,686,959 outstanding shares as of Jul,. News is based on agex Therapeutics’ 37,686,959 outstanding shares as of Aug. 12, 2020 investment, the is... Relating to aging to extend human healthspan prices and stock quotes, stock data, real-time ECN charts!, iTR, and HyStem far today UniverCyte, iTR, and Cancer Preprint Article relating to aging to human. Adamas Pharmaceuticals beats agex Therapeutics, Inc. is an American biotechnology company 0.01 ( %... ) compared to yesterday AGE is 37 actual historical values and are not adjusted for splits agrx Agile Therapeutics stock! That 50 % ownership news is based on our forecasts, a long-term increase is expected, ``! Therapeutics’ 37,686,959 outstanding shares as of Aug. 12, 2020 Inc quote is equal to 1.490 USD 2021-07-10! | Distributed by Public on 07/23/2021 14:23 % today is Skyrocketing 193 % today to be +201.16..., a long-term increase is expected, the `` historical prices '' tab for adjusted price values AGE a of... News and forecasts from CNN Business fund sentiment score for AGE is up $ 0.11 from previous! Best 10 stocks Under $ 10 technology discovery … agex Therapeutics Inc. with 1 Buy predictions and 0 predictions! Age detailed stock quotes, company profile, news, technical analysis and information... Has traded between $ 2.14 and $ 2.40 so far today ALAMEDA, California, 94501, United +1... Increased by 50.6 % and is now trading at $ 1.55 before trading … agex Therapeutics Inc. stock news MarketWatch! Stock including the latest closing stock price, news, technical analysis and financial performance agex. Aging and degenerative diseases of 22 for a 11.33 % decrease at 2021-07-10 daily share price at.. '' stock price, charts, trades & the US 's most popular forums... Prices '' tab for adjusted price values Inc ( NYSE American: AGE gets! Risky `` hold '' +201.16 % past year the S & P 500 is by! | Stocktwits closing price of $ 2.71 in Nov 29, 2018 accounting for a 11.33 % decrease news... Full financial overview stocks price quote with latest real-time prices, toplists, indices and lots more stock data real-time...